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Hospitalization to initiate hemodialysis (HD) through temporary catheterization and subsequent
creation of permanent vascular access (VA) is costly. Therefore, we studied the influence of the
timing of VA creation on medical expenses, length of stay (LOS) and 1-year primary patency rate
in incident HD patients. We analyzed the medical expenses associated with hospitalization and
LOS at VA creation in 486 incident HD patients at two hospitals in southern Taiwan. Patients with
early VA creation, more than 1 month before HD initiation, were defined as the Planned group
(n = 70); less than 1 month as the Delayed group (n = 48); and those with VA creation after the ini-
tiation of HD as the Urgent group (n = 368). The Urgent group had the highest inpatient medical
expenses and LOS compared with the other two groups. Multiple regression analyses of inpatient
medical expenses and LOS showed that the timing of VA creation, the type of VA, marital and
employment status and the number of comorbidities were significant factors responsible for the
differences between groups. Furthermore, higher inpatient medical expenses and longer LOS in
the Urgent group were noted in the arteriovenous fistula and arteriovenous graft subgroups.
Kaplan-Meier Survival analysis showed that the 1-year primary patency rate was highest in the
Delayed group and lowest in the Planned group, while Cox regression analysis demonstrated
that the type of VA, but not the timing of VA creation, was a significant risk factor for VA patency.
Arteriovenous graft had a higher risk for occlusion than arteriovenous fistula. In conclusion,
planned VA creation before the initiation of HD is associated with lower inpatient medical expenses
and shorter LOS, which should be promoted for pre-end-stage renal disease care, but the care for
VA should be further emphasized before the progression to end-stage renal disease, and the
patency of the VA should be cautiously monitored.
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In Taiwan, 90% of end-stage renal disease (ESRD)
patients select hemodialysis (HD) as the treatment
mode. Most of the patients who select HD (82%) have
a native arteriovenous fistula to provide vascular
access (VA), while only 18% of patients use an artificial
arteriovenous graft [1]. However, less than 10% of
incident HD patients undergo VA creation before the
initiation of dialysis [2]. Most patients initiate HD with
the insertion of a non-cuffed temporary catheter while
hospitalized, and the surgical construction of VA is
then done during hospitalization. After discharge, the
temporary catheter is used for VA for about 1 month
until the permanent VA, either the native arteriove-
nous fistula (AVF) or the artificial arteriovenous graft
(AVG), is mature enough to replace the function of the
temporary catheter. This situation will theoretically
increase the duration of hospitalization and the med-
ical expenses. Furthermore, even when the nephrolo-
gists successfully persuade the patients to accept the
arrangement of VA construction before the initiation
of dialysis, this surgical procedure is almost always
done during hospitalization instead of day surgery.
Dialysis therapy consumes more than 7% of the
annual budget of the National Health Insurance in
Taiwan, and has thus become a heavy financial 
burden [3]. Information pertaining to the medical
expenses on the timing of the creation of both types
of VA is needed to promote better and more econom-
ical pre-ESRD care. The purpose of this study was to
investigate the effect of the timing of VA creation and
the type of VA on the medical expenses incurred due
to hospitalization and length of stay (LOS) for VA
creation in incident HD patients. We also explored
the 1-year primary patency rate among groups with
VA creation at different times, and between the two
types of VA.
MATERIALS AND METHODS
This retrospective study involved 486 incident HD
patients who initiated HD between January 1, 2001
and December 31, 2003 at two medical university
affiliated hospitals, one was a medical center and the
other was a district hospital, within the same man-
agement system in southern Taiwan. All patients sur-
vived longer than 3 months after initiating dialysis.
Demographic information including age, sex, marital
status, education level, employment status, medical
conditions and underlying disease, number of comor-
bidities (comorbidities evaluated included hyperten-
sion, congestive heart disease, ischemic heart disease,
cerebrovascular disease, liver disease, malignancy,
and tuberculosis), timing of VA creation, types of VA,
days of hospitalization, and total inpatient medical
expenses were obtained by examining National Health
Insurance claims data through the medical informat-
ics system at each hospital. The total inpatient expenses
covered the general care fee, expenses associated with
the creation of VA and insertion of the temporary non-
cuffed catheter, but excluded the expenses associated
with hemodialysis during hospitalization, because it
comprised a fixed expense for every dialysis patient.
Because all of the patients underwent VA creation,
dialysis therapy, and subsequent care at these two
hospitals, there was no loss of inpatient claims data
for each patient during the study period.
Based on the timing of VA creation, the patients
were divided into three groups: the Planned group
(n = 70, 14.4%) with VA creation more than 1 month
before the initiation of HD; the Delayed group (n = 48,
9.9%) with VA creation within 1 month before the first
dialysis; and the Urgent group (n = 368, 75.8%) with
VA creation after the initiation of HD.
The primary aim of this study focused on the med-
ical expenses associated with hospitalization and LOS
at VA creation. We also compared the 1-year primary
patency rate among the three groups with different
timing of VA creation, and analyzed factors influenc-
ing the outcome of VA. The overall observation period
started on the date of VA creation and ended 365 days
later. Reconstruction of the VA, thrombectomy or
angioplasty within the observation period were con-
sidered events of interest. Patients who did not expe-
rience these events or who died during the observation
period were censored. Death was confirmed using
the National Death Registry from the Department of
Health. Data are expressed as mean± standard error of
the mean. Differences in distribution between the three
groups were evaluated using χ2 tests. Multiple regres-
sion analyses were used to establish predictive models
for medical expenses and LOS after log transforma-
tion. For survival analysis, the Kaplan-Meier method
was used to estimate the 1-year primary patency rate
and Cox’s regression model was used to analyze the
potential risks for vascular occlusion over 1 year. A
p value > 0.05 was taken to be significant. Data entry
and management were performed on Microsoft SQL,
and all analyses were performed using SPSS version
12.0 (SPSS Inc., Chicago, IL, USA) for Windows.
RESULTS
Demographic data, prevalence of underlying diseases,
and VA-associated information for the three groups
are shown in Table 1. Middle-aged and elderly patients
constituted 90.7% of the patients, and over half of the
patients were female (56.2%). About two-thirds of the
patients had an education level below 6 years (primary
school), and only 11% were single. However, 85.9% of
patients were unemployed or retired. Diabetes was
the most common underlying disease (41.8%) fol-
lowed by glomerulonephritis (36.8%). A total of 192
(39.5%) patients had cardiovascular diseases (conges-
tive heart disease or ischemic heart disease), and most
patients had at least one comorbidity (86.5%). There
were 407 cases of AVF (83.7%) and 79 of AVG (16.3%).
No significant difference was noted in age, sex,
employment status or education level among the
three groups, although marital status showed weak
but significant differences (Table 1). Furthermore,
most (75%) of the incident HD patients did not have
a permanent VA at the initiation of HD.
The inpatient medical expenses and LOS at the
first VA creation for the three groups are shown in
Figure 1. In the full population (left panel), signifi-
cant differences were noted among the three groups
according to the time of VA creation. The Urgent
group was associated with the highest inpatient med-
ical expenses and the longest LOS, while the Planned
group had the lowest inpatient medical expenses and
the shortest LOS. The inpatient expenses and the LOS
in the patients who received AVF or AVG based on the
same criteria of grouping showed a similar pattern;
however, longer LOS and higher inpatient medical
expenses were noted in the AVG group compared with
the AVF group (Figure 1, middle and right panels).
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Table 1. Demographics, underlying diseases and vascular access data for the complete study population and for the
three groups of patients*
Items All (n = 486) Planned group Delayed group Urgent group p†
(n = 70) (n = 48) (n = 368)
Age (yr) 0.242
< 45 45 (9.3) 2 (2.9) 5 (10.4) 38 (10.3)
45–64 216 (44.4) 30 (42.9) 24 (50.0) 162 (44.0)
≥ 65 225 (46.3) 38 (54.2) 19 (39.6) 168 (45.7)
Sex (male) 213 (43.8) 30 (42.9) 25 (52.1) 158 (42.9) 0.478
Education 0.374
≤ 6 yr 330 (67.9) 50 (71.4) 25 (52.1) 255 (69.3)
7–9 yr 84 (17.3) 11 (15.7) 13 (27.1) 60 (16.3)
10–12 yr 51 (10.5) 6 (8.6) 7 (14.6) 38 (10.3)
> 12 yr 21 (4.3) 3 (4.3) 3 (6.3) 15 (4.1)
Marital status (married) 433 (89.0) 66 (95.7) 46 (95.8) 319 (86.9) 0.028
Employment status (employed) 69 (14.1) 8 (13.0) 12 (26.1) 49 (12.7) 0.072
Underlying diseases 0.302
Glomerulonephritis 179 (36.8) 28 (40.00) 17 (35.4) 134 (36.4)
Diabetes mellitus 203 (41.8) 22 (31.43) 23 (47.9) 158 (42.9)
Other diseases 104 (21.4) 20 (28.57) 8 (16.7) 76 (20.7)
Comorbidities‡ 0.354
None 66 (13.6) 14 (20.00) 4 (8.3) 48 (13.0)
1 219 (45.1) 27 (38.57) 25 (52.1) 167 (45.4)
≥ 2 201 (41.4) 29 (41.43) 19 (39.6) 153 (41.6)
Type of VA 0.235
Native AV fistula 407 (83.7) 54 (77.14) 42 (87.5) 311 (84.5)
Artificial AV graft 79 (16.3) 16 (22.86) 6 (12.5) 57 (15.5)
*Data are presented as n (%); †differences among the three groups were examined by χ2 tests (significant differences were considered
at p < 0.05); ‡comorbidities included hypertension, congestive heart disease, ischemic heart disease, cerebrovascular disease, liver 
disease, malignancy, and tuberculosis. VA = vascular access; AV = arteriovenous.
Multiple regression analyses on inpatient medical
expenses and on LOS showed broadly similar results
that the timing of VA creation, type of VA, marital sta-
tus, employment status, and number of comorbidities
were significant factors associated with the differences
in inpatient medical expenses (Model 1 in Table 2) and
in LOS (Model 2 in Table 2). After adjusting for demo-
graphic and disease factors, the Planned group had
lower inpatient medical expenses than the Urgent
group, while the Delayed group was lower than the
Urgent group. Patients with more comorbidities had
higher inpatient medical expenses than patients with
glomerulonephritis. Similar results were noted in LOS.
During the observation period, 47 (9.6%) patients
were lost to follow up, and the mean follow-up time
was 336 days. Table 3 shows the events and rates of
VA occlusion that occurred before and after the initia-
tion of dialysis in all three groups. There were no
episodes of VA occlusion before initiating dialysis.
However, the Delayed group had the lowest VA
occlusion rate at 1 year after dialysis. In contrast, the
Planned group had the highest frequency of VA
occlusion. Kaplan-Meier analysis also demonstrated
that the Delayed group had a higher 1-year primary
patency rate of VA than the Planned group and the
Urgent group, irrespective of AVF or AVG (Figure 2).
However, the Cox regression model revealed that the
type of VA (hazard ratio: 3.1, 95% confidence inter-
val: 1.4–6.8), but not the timing of VA creation, was a
significant risk factor for VA patency, after adjusting
for potential confounding factors (Table 4). The arte-
riovenous graft had a higher risk for occlusion than
the arteriovenous fistula.
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Figure 1. (A) Inpatient medical expenditure and (B) length of hospital stay according to the time of first vascular access creation are
shown for all patients, patients with an arteriovenous fistula, and patients with an arteriovenous graft, respectively. Data are expressed
as mean ± standard error of the mean, and were statistically analyzed by the Kruskal-Wallis test. Significant differences among groups
are defined as p < 0.05. *p < 0.001. AVF = arteriovenous fistula; AVG = arteriovenous graft.
Table 2. Multiple regression analyses on inpatient
expenses and length of hospitalization for the first
instance of vascular access creation*
Model 1 Model 2 
(β × 103) (β × 103)
Timing of VA creation 
(Urgent group)
Planned group −314.1† −436.4†
Delayed group −129.6‡ −179.0‡
Type of VA (AVF) 153.1† 109.7§
Age (each 1 yr) 67.3§ 57.9
Sex (female) −0.2 −1.3
Education (≤ 6 yr)
7–9 yr 33.4 56.3
10–12 yr 40.6 77.6
> 12 yr 112.6 182.4
Marital status (married) 119.2§ 136.4§
Employment status −106.7§ −184.2‡
(employed)
Underlying diseases 
(glomerulonephritis)
Diabetes mellitus 70.5§ 80.3
Other diseases 53.0 48.3
Number of comorbidities 72.5† 94.7†
(for each type of comorbidity)
*Multiple regression analysis: items in the first column of 
the table within the parentheses were used as the reference
and statistical significance was accepted at p < 0.05. Expenses
are in United States dollars, excluding dialysis expenses, 
and length of stay in days are transformed into logarithmic
values. Model 1 = inpatient medical expenses model, Adjusted
R2 = 20.7%, F = 10.7, p < 0.001; Model 2 = length of stay model,
Adjusted R2 = 21.6%, F = 9.9, p < 0.001; †p < 0.001; ‡p < 0.01;
§p < 0.05. VA = vascular access; AVF = arteriovenous fistula.
DISCUSSION
The present study examined whether the timing of
VA creation and the type of VA affect the medical
expenditure associated with the first hospitalization
for VA creation in incident HD patients. The results
demonstrate that creating the VA before initiating
HD significantly decreased inpatient expenses and
shortened the LOS.
Problems associated with VA are the most fre-
quently encountered conditions in HD patients [4–6].
These do not just relate to mortality and morbidity
[7], but also contribute to a significant portion of the
medical expenses incurred in the care of HD patients
[8]. In addition, these problems are the main causes
of hospitalization and medical utilization, particu-
larly in the first 3 months after initiating HD [9]. 
A similar finding was noted in Taiwan where the
problems associated with VA constitute a significant 
portion of hospitalization and increase the inpatient
expenses in HD patients [10]. Meanwhile, Hwang et al
reported that the medical expenses incurred 6 months
after the initiation of HD are lower in the patients 
in whom the VA was created before starting HD [2].
Despite the consistent conclusions from various
studies, the concept of creating VA before initiation of
dialysis still needs to be emphasized.
In this study, there were 75% incident HD patients
who initiated HD through a temporary catheter, via
the internal jugular, subclavian or femoral veins,
between 2001 and 2003. This delay in preparation for
renal replacement therapy may result from several
situations commonly noted in other countries. These
include late referral to nephrologists by the primary
care physicians or other specialists, lack of insight and
ignorance of ESRD by the patients themselves, poor
Planned VA creation saves expenses
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Table 3. Number of events of vascular access occlusion in three observation periods according to the time of vascular
access creation*
Number of events Before dialysis 0–3 mo after dialysis 3–12 mo after dialysis Overall
Planned group (n = 70) 0 (0) 6 (8.6) 4 (5.7) 10 (14.3)
Delayed group (n = 48) 0 (0) 0 (0) 1 (2.1) 1 (2.1)
Urgent group (n = 368) 0 (0) 9 (2.4) 12 (3.3) 21 (5.7)
All groups (n = 486) 0 (0) 15 17 32 (6.6)
*Data presented as n (%).
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Figure 2. Kaplan-Meier survival analysis for the 1-year primary patency rate of vascular access according to the time of vascular
access creation. (A) Arteriovenous fistula; (B) arteriovenous graft. The log rank test was used to determine the differences in 1-year
primary patency rate within each group, and p < 0.05 was considered statistically significant. AVF = arteriovenous fistula; AVG =
arteriovenous graft.
psychological preparedness of the patients for dialysis,
and sudden onset of acute conditions that are beyond
the control of nephrologists [11–15].
Because all of the VA creations in this study were
exclusively performed by cardiovascular surgeons
during hospitalization in study hospitals, every inci-
dent HD patient had only one record of hospitaliza-
tion for the first VA creation. Additionally, the expenses
related to the medical problems associated with VA
before and after the initiation of HD were not included
in this study. This definition simplified the compar-
isons and increased their applicability, and it allows
us to focus on the specific hospitalization. The results
revealed significantly less inpatient medical expendi-
ture and shorter LOS in patients who received early
and planned VA creation more than 1 month before
the initiation of HD (Planned group), as compared
with patients who had VA creation after HD (Urgent
group). The Delayed group had medical expenses and
LOS that were in between the other two groups. This
relationship between higher medical expenses and
longer LOS was expected for patients in whom the
VA was not created until the appearance of severe
uremic complications. Because of the increase in risk
and the complications associated with ESRD, the time
involved in managing emergent conditions and wait
for surgery could be longer, and thus it is reasonable
that the inpatient medical expenses and LOS were
increased. From the above results, early preparation
of VA for patients with either advanced renal failure,
or morbid conditions, should be a priority for chronic
kidney diseases (CKD) and pre-ESRD education.
The cost-saving effect was consistent in both the
AVF and AVG groups, and was more pronounced in
the AVF group than in AVG group. The expenditure
associated with creating an AVF is less than that for
AVG, which is the main reason for the lower medical
expenses in the AVF group. In addition, the overall
prognosis of AVF was reported to be much better than
for AVG [7,16–18]. The percentage of VA with AVF in
our patients (83.7%) was much higher than that in
Western countries [12,16,18–20]. The preference for
AVF by nephrologists and vascular surgeons for inci-
dent HD patients offers an advantage to reduce
expenses associated with the creation of VA. Because
the time needed for maturation of AVF is usually
longer, patients in the Urgent group previously had a
double lumen catheter inserted for HD before the mat-
uration of the AVF, and this procedure also requires a
longer time for maturation of the VA. Various com-
plications can occur during this period, including
catheter infection, catheter occlusion, cosmetic prob-
lems and inconvenience in daily activity. Hidden
expenses incurred during the waiting time for matu-
ration of VA in the Urgent group were not apparent,
and could not be expressed in the present study. In
general, to minimize the potential increase in costs,
we need to emphasize the importance of early VA
preparation before initiating long-term dialysis.
Occlusion of VA, which requires angioplasty or
surgical reconstruction, is still a major problem that
affects HD patients [20,21]. Occlusion not only affects
the dialysis treatment but is associated with signifi-
cant medical expenditure [16]. This study shows that
the Planned group had lower medical expenses and
shorter length of hospitalization compared with those
in the Delayed group and the Urgent group. Despite
the unexpected higher 1-year patency rate in the
Delayed group compared with the Planned group, the
Cox regression model demonstrates the non-signifi-
cant role of the timing of VA creation on the 1 year VA
primary patency, but the type of VA (AVG vs. AVF)
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Table 4. Cox proportional hazard model for vascular
occlusion
Variables
Adjusted 
95% CI
hazard ratio
Timing of VA creation 
(Urgent group)
Planned group 0.15 0.95–4.53
Delayed group 0.46 0.21–1.01
Type of VA (AVF) 3.11 1.41–6.84
Age (each 1 yr) 1.07 0.53–2.18
Sex (female) 1.09 0.51–2.36
Education (≤ 6 yr)
7–9 yr 2.33 0.93–5.86
10–12 yr 1.25 0.25–6.30
> 12 yr 1.89 0.19–19.2
Marital status (married) 0.96 0.29–3.26
Employment status 
(employed) 0.37 0.07–2.02
Underlying diseases 
(glomerulonephritis)
Diabetes mellitus 0.47 0.15–1.44
Other diseases 0.86 0.40–1.84
Number of comorbidities 0.91 0.59–1.39
(for each type of comorbidity)
CI = confidence interval; VA = vascular access; AVF = arteriove-
nous fistula.
was a significant risk factor. These results reflect the
following two points. First, the optimal timing for 
VA creation should be balanced between the risk of
emergency HD without the creation of a VA and the
risk of occlusion with VA created at an earlier stage.
Second, the care of VA before the initiation of HD
should be strengthened by involving nurses who care
for CKD patients as HD nurses, and training exer-
cises to increase VA blood flow should be reinforced
at the pre-ESRD stage after VA creation.
The limitation of this study is the relative small
number of studied cases and the unequal distribution
of the case numbers among the three groups. How-
ever, the parameters for analysis were not statistically
different after grouping. As a retrospective study,
personal psychological factors for acceptance of VA
creation and dialysis, socioeconomic factors that influ-
ence the decision-making on dialysis initiation, and
the surgical technique used to create the VA, which
might affect grouping, were not surveyed in this
study. Nevertheless, a project to prevent CKD, which
was launched in 2003 in Taiwan, emphasizes the
importance of VA creation before initiating dialysis.
After introducing this concept, the rate of creating
VA in pre-ESRD patients, who joined the CKD care
program, has increased to 41.2% in 2005 [22].
In conclusion, we have demonstrated the cost-
saving effect of early VA preparation for HD patients
and the preference for AVF as permanent VA. Our
results provide evidence for reducing the medical
expenses if the VA is created before initiating HD.
However, maintaining the patency of VA is essential
for pre-ESRD care.
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計劃性建立血管通路對新進入血液透析患者
住院醫療費用之影響
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慢性腎臟病患若未有妥善的透析前準備，於情況緊急時再經由住院透析，則除必須放
置暫時性導管、執行緊急血液透析外，另需於病情穩定後再建立血管通路，勢必增加
住院時日而導致耗用較高的醫療費用。假設慢性腎臟病患者若能於進入血液透析前，
即有計畫地建立血管通路，是否可降低開始透析時期之醫療費用與醫療利用，且能維
持較好的血管通路功能。本研究主要目的是探討初次進入血液透析之患者，血管通路
建立時機對醫療費用、住院天數及一年內血管通路之功能。研究針對南部某醫學中心
與區域教學醫院初次接受血液透析之 486 位患者，其中 70 位於透析前一個月以上建
立血管通路為計劃組、48 位於透析前一個月內建立者為延遲組及進入透析後才建立之 
368 位為緊急組，進行分析。結果發現緊急組不論是建立動靜脈瘻管或人工血管者，
其住院醫療費用與住院天數高於其他兩組。複迴歸分析顯示血管通路建立時機、型
式、婚姻與工作狀況及合併症是住院醫療費用及天數之主要影響因子。雖然以 
Kaplan-Meier 方法測得一年內血管通路通暢率，以延遲組最高而計畫組反而最低，
但是 Cox 迴歸模式卻證明血管通路的形式為通暢與否最有意義的危險因子，而與建立
時機無關。人工血管較自體動靜脈瘻管發生阻塞的危險性高。結論，慢性腎臟病患者
於進入血液透析前有計畫的建立血管通路，將可降低住院醫療費用及住院天數，但是
應於透析前的慢性腎臟病時期加強血管通路的照護，以維持良好的血管通路功能。
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